rs13306567

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_005957.5(MTHFR):​c.476-86G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0442 in 969,490 control chromosomes in the GnomAD database, including 1,165 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.037 ( 153 hom., cov: 32)
Exomes 𝑓: 0.045 ( 1012 hom. )

Consequence

MTHFR
NM_005957.5 intron

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -2.14

Publications

17 publications found
Variant links:
Genes affected
MTHFR (HGNC:7436): (methylenetetrahydrofolate reductase) The protein encoded by this gene catalyzes the conversion of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, a co-substrate for homocysteine remethylation to methionine. Genetic variation in this gene influences susceptibility to occlusive vascular disease, neural tube defects, colon cancer and acute leukemia, and mutations in this gene are associated with methylenetetrahydrofolate reductase deficiency.[provided by RefSeq, Oct 2009]
MTHFR Gene-Disease associations (from GenCC):
  • homocystinuria due to methylene tetrahydrofolate reductase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 1-11800408-C-G is Benign according to our data. Variant chr1-11800408-C-G is described in ClinVar as Likely_benign. ClinVar VariationId is 1300897.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0528 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005957.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MTHFR
NM_005957.5
MANE Select
c.476-86G>C
intron
N/ANP_005948.3
MTHFR
NM_001330358.2
c.599-86G>C
intron
N/ANP_001317287.1
MTHFR
NM_001410750.1
c.596-86G>C
intron
N/ANP_001397679.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MTHFR
ENST00000376590.9
TSL:1 MANE Select
c.476-86G>C
intron
N/AENSP00000365775.3
MTHFR
ENST00000423400.7
TSL:1
c.596-86G>C
intron
N/AENSP00000398908.3
MTHFR
ENST00000376592.6
TSL:1
c.476-86G>C
intron
N/AENSP00000365777.1

Frequencies

GnomAD3 genomes
AF:
0.0371
AC:
5646
AN:
152164
Hom.:
151
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0109
Gnomad AMI
AF:
0.0362
Gnomad AMR
AF:
0.0406
Gnomad ASJ
AF:
0.0541
Gnomad EAS
AF:
0.00211
Gnomad SAS
AF:
0.0420
Gnomad FIN
AF:
0.0317
Gnomad MID
AF:
0.0728
Gnomad NFE
AF:
0.0543
Gnomad OTH
AF:
0.0416
GnomAD4 exome
AF:
0.0455
AC:
37172
AN:
817208
Hom.:
1012
Cov.:
11
AF XY:
0.0458
AC XY:
19784
AN XY:
432046
show subpopulations
African (AFR)
AF:
0.0104
AC:
220
AN:
21098
American (AMR)
AF:
0.0279
AC:
1200
AN:
42940
Ashkenazi Jewish (ASJ)
AF:
0.0494
AC:
1085
AN:
21958
East Asian (EAS)
AF:
0.00492
AC:
180
AN:
36560
South Asian (SAS)
AF:
0.0379
AC:
2773
AN:
73138
European-Finnish (FIN)
AF:
0.0314
AC:
1594
AN:
50842
Middle Eastern (MID)
AF:
0.115
AC:
515
AN:
4468
European-Non Finnish (NFE)
AF:
0.0529
AC:
27866
AN:
527092
Other (OTH)
AF:
0.0445
AC:
1739
AN:
39112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1944
3888
5831
7775
9719
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
594
1188
1782
2376
2970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0371
AC:
5651
AN:
152282
Hom.:
153
Cov.:
32
AF XY:
0.0372
AC XY:
2768
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.0109
AC:
452
AN:
41546
American (AMR)
AF:
0.0405
AC:
620
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0541
AC:
188
AN:
3472
East Asian (EAS)
AF:
0.00212
AC:
11
AN:
5190
South Asian (SAS)
AF:
0.0419
AC:
202
AN:
4824
European-Finnish (FIN)
AF:
0.0317
AC:
336
AN:
10614
Middle Eastern (MID)
AF:
0.0748
AC:
22
AN:
294
European-Non Finnish (NFE)
AF:
0.0543
AC:
3692
AN:
68020
Other (OTH)
AF:
0.0450
AC:
95
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
275
551
826
1102
1377
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
70
140
210
280
350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0374
Hom.:
19
Bravo
AF:
0.0363
Asia WGS
AF:
0.0320
AC:
110
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Apr 16, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
3.1
DANN
Benign
0.44
PhyloP100
-2.1
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.17
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs13306567; hg19: chr1-11860465; API